120 related articles for article (PubMed ID: 17525560)
1. Fatal neurotoxic response to neuroleptic medications: case report and review of the literature.
Sheil AT; Collins KA; Schandl CA; Harley RA
Am J Forensic Med Pathol; 2007 Jun; 28(2):116-20. PubMed ID: 17525560
[TBL] [Abstract][Full Text] [Related]
2. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
Picard LS; Lindsay S; Strawn JR; Kaneria RM; Patel NC; Keck PE
Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
[TBL] [Abstract][Full Text] [Related]
3. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
[TBL] [Abstract][Full Text] [Related]
4. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
5. [Neuroleptic malignant syndrome: a rare long lasting case report].
Lemos J; Mós M; Monteiro A; Henriques P
Acta Med Port; 2010; 23(6):1155-9. PubMed ID: 21627894
[TBL] [Abstract][Full Text] [Related]
6. [Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS].
Andreassen MD; Pedersen S
Ugeskr Laeger; 2000 Mar; 162(10):1366-70. PubMed ID: 10745673
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of neuroleptic malignant syndrome.
Guerrero RM; Shifrar KA
Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
[TBL] [Abstract][Full Text] [Related]
8. [Neuroleptic malignant syndrome in a patient with polyneuropathy: mechanism of muscle rigidity and elevated serum creatine kinase levels].
Takashima S; Hirade S; Taguchi Y; Inoue H
Rinsho Shinkeigaku; 1998; 38(10-11):955-7. PubMed ID: 10203983
[TBL] [Abstract][Full Text] [Related]
9. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L
Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic malignant syndrome: a report of a case and review of the literature.
Kanchanapongkul J
J Med Assoc Thai; 1991 Oct; 74(10):481-4. PubMed ID: 1686780
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptic malignant syndrome with delayed onset of fever following risperidone administration.
Norris B; Angeles V; Eisenstein R; Seale JP
Ann Pharmacother; 2006 Dec; 40(12):2260-4. PubMed ID: 17119106
[TBL] [Abstract][Full Text] [Related]
12. An autopsy case of neuroleptic malignant syndrome (NMS) and its immunohistochemical findings of muscle-associated proteins and mitochondria.
Kubo S; Orihara Y; Kitamura O; Ikematsu K; Tsuda R; Nakasono I
Forensic Sci Int; 2001 Jan; 115(1-2):155-8. PubMed ID: 11056287
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
Ward C
J Neurosci Nurs; 2005 Jun; 37(3):160-2. PubMed ID: 16001822
[TBL] [Abstract][Full Text] [Related]
14. [A study of neuroleptic malignant syndrome in the presenium and senium].
Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
[TBL] [Abstract][Full Text] [Related]
15. Neuroleptic malignant syndrome: a review and report of six cases.
Kasantikul D; Kanchanatawan B
J Med Assoc Thai; 2006 Dec; 89(12):2155-60. PubMed ID: 17214072
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic malignant syndrome secondary to quetiapine.
Gortney JS; Fagan A; Kissack JC
Ann Pharmacother; 2009 Apr; 43(4):785-91. PubMed ID: 19299325
[TBL] [Abstract][Full Text] [Related]
17. Case study: neuroleptic malignant syndrome without pyrexia.
Hynes AF; Vickar EL
J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):959-62. PubMed ID: 8768358
[TBL] [Abstract][Full Text] [Related]
18. Neuroleptic malignant syndrome: a concealed diagnosis with multitreatment approach.
Velosa A; Neves A; Barahona-Corrêa JB; Oliveira-Maia AJ
BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31213433
[TBL] [Abstract][Full Text] [Related]
19. An atypical presentation of neuroleptic malignant syndrome: diagnostic dilemma in a critical care setting.
Paul M; Michael SG; John S; Lenox RJ
Respir Care; 2012 Feb; 57(2):315-7. PubMed ID: 21762565
[No Abstract] [Full Text] [Related]
20. Postmortem molecular screening for mutations in ryanodine receptor type 1 (RYR1) gene in psychiatric patients suspected of having died of neuroleptic malignant syndrome.
Sato T; Nishio H; Iwata M; Kentotsuboi ; Tamura A; Miyazaki T; Suzuki K
Forensic Sci Int; 2010 Jan; 194(1-3):77-9. PubMed ID: 19931341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
